Cargando…
Predictors of Mortality in Patients with Chronic Heart Failure: Is Hyponatremia a Useful Clinical Biomarker?
BACKGROUND: Chronic heart failure (CHF) is a global health burden. Despite advances in treatment, there remain well-recognised morbidity and mortality. Risk stratification requires the identification and validation of biomarkers, old and new. Hyponatremia has re-emerged as a prognostic marker in CHF...
Autor principal: | Alem, Manal M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381090/ https://www.ncbi.nlm.nih.gov/pubmed/32765046 http://dx.doi.org/10.2147/IJGM.S260256 |
Ejemplares similares
-
Racial differences and mortality risk in patients with heart failure and hyponatremia
por: Miles, Jeremy A., et al.
Publicado: (2019) -
Tolvaptan, hyponatremia, and heart failure
por: Zmily, Hammam D, et al.
Publicado: (2011) -
Clinical, Echocardiographic, and Therapeutic Characteristics of Heart Failure in Patients with Preserved, Mid-Range, and Reduced Ejection Fraction: Future Directions
por: Alem, Manal M
Publicado: (2021) -
Hyponatremia during hospitalization and in-hospital mortality in patients hospitalized from heart failure
por: Saepudin, S., et al.
Publicado: (2015) -
Clinical utility of tolvaptan in the management of hyponatremia in heart failure patients
por: Nodari, Savina, et al.
Publicado: (2010)